耐多药结核病疫情与控制  

Multi Drug Resistant Tuberculosis and Control

作　　者：罗俊毅[1] 

机构地区：[1]南充市疾病预防控制中心,四川南充637000

出　　处：《预防医学情报杂志》2011年第3期217-220,共4页Journal of Preventive Medicine Information

摘　　要：20世纪90年代以来,结核病疫情在全球范围内卷土重来。据WHO估算,全球大约有1/3的人口感染结核,每年约有900万新发结核病患者,其中耐多药结核病(MDR-TB)发病人数约30～60万,实际耐多药结核病患病人数可能接近或超过100万,而中国的MDR-TB患者人数占全球的1/4～1/3。耐药结核尤其是耐多药结核病的发生和流行是当前结核病疫情回升的主要原因之一,已成为结核病控制的重要障碍。现对全球耐多药结核病疫情与控制进行综述,以期为进一步深入研究提供方向。Since 1990s,tuberculosis（TB） epidemic had reemerged in the world.WHO estimated that probably 1/3 of the world population is infected with tuberculosis,nearly 9 million new TB patients are found every year,of which 300 000-600 000 were multi drug resistant-TB（MDR-TB） patients,but the actual number of MDR-TB patients is more than 1 million,and the number of MDR-TB patient in China accounts for 1/4-1/3 of the world total.Drug resistant TB,especially MDR-TB,is one of the main causes of the reemergence of TB and the obstacles of TB control.This paper summarizes the MDR-TB epidemic and the control in the world to guide the further study of TB prevention and control.

关 键 词：结核 耐多药 疫情 控制 

分 类 号：R521[医药卫生—内科学]